HOME Research Insight Product Launches and Acquisitions were the Key Strategies Adopted by Leading Market Players to Foster their Growth in the Global Infertility Treatment Market



Product Launches and Acquisitions were the Key Strategies Adopted by Leading Market Players to Foster their Growth in the Global Infertility Treatment Market


The key players in the infertility treatment market focus on various strategies such as product approvals, launches, and enhancements; agreements, partnerships, and collaborations; strategic acquisitions; and geographic expansions to increase their market shares in the global market. Strategic acquisitions and product launches were the key strategies adopted by major industry players to achieve growth in the infertility treatment market. These strategies were majorly adopted by The Cooper Companies, Inc. (U.S.), Cook Group Incorporated (U.S.), Siemens AG (Germany), and Thermo Fisher Scientific (U.S.). Apart from product approvals, launches, and enhancements many prominent players also adopted agreements, partnerships, and collaborations as one of their growth strategies to strengthen their market presence.

The Cooper Companies, Inc. (U.S) held the leadership position in the global infertility treatment market, in 2015. The company operates through two business units namely- CooperVision (CVI) and CooperSurgical (CSI). The CooperSurgical business segment offers a wide range of products and services focused on women's health, fertility, and diagnostics. The company sells its products in over 100 countries and has its presence across the U.S., Europe, and RoW. It pursues growth strategies such as strategic acquisitions. During 2016, CooperSurgical a women’s healthcare business unit of the Cooper Companies, Inc. acquired the in-vitro fertilization (IVF) segment-Wallace, from Smiths Medical (U.K.), Genesis Genetics (U.S.), and acquired commercial assets of Recombine Inc. (U.S.).

Moreover, Cook Group Incorporated (U.S.) held the second position in the global infertility treatment market, in 2016. The company’s notable subsidiaries include Cook Incorporated (U.S.), Sabin Corporation (U.S.), Cook Vascular Incorporated (U.S.), Cook Biotech Incorporated (U.S.), and Cook Medical Incorporated (U.S.). The company primarily operates in Australia, Canada, Denmark, Ireland, and the U.S. and distributes its products in 135 countries. In order to further strengthen its position and to gain a larger share in the infertility treatment diagnostics industry, the company focuses on growth strategies such as product showcases and expansions. For instance, in November 2015, Cook Medical opened a new distribution center, namely, South Asia Distribution Centre (SADC) in Singapore. This new distribution center was aimed to meet the increasing product demand across India, Korea, Malaysia, Taiwan, Thailand, and Hong Kong. This expansion helped the company to strengthen its market presence in the APAC region. In September 2014, the company showcased its 12 reproductive health product categories at the national Brazilian REDLARA meeting, based on the ‘Embryo and Blastocyst Biopsy.' This helped the company to strengthen its market presence in Brazil.

Related Reports:

Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports